- $30.71m
- $10.64m
- $27.08m
- 52
- 67
- 37
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 30.5 | 22.6 | 24.3 | 26.9 | 27.1 |
Cost of Revenue | |||||
Gross Profit | 10.8 | 10.6 | 11.9 | 11.6 | 11.7 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 38.7 | 26.9 | 24.2 | 28.5 | 29.7 |
Operating Profit | -8.24 | -4.34 | 0.067 | -1.53 | -2.66 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.84 | -4.22 | 0.068 | -1.39 | -1.47 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.85 | -4.28 | 0.054 | -1.44 | -1.54 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -7.85 | -4.28 | 0.054 | -1.44 | -1.54 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.85 | -4.28 | 0.054 | -1.44 | -1.54 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.304 | -0.168 | -0.032 | -0.048 | -0.051 |